S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
MB
INSIDER · TRDA · Entrada Therapeutics, Inc. · 10% OWNER

MPM BIOVENTURES 2018, L.P.

Every open-market transaction filed under this name, Aug 24 to Sep 3.

Filings
9
0 buys · 9 sells
Bought
open market, at cost
Sold
$1.7M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 3TRDAEntrada Therapeutics, Inc.10% ownerSell32,263$7.17$231K−0.6%
Sep 2TRDAEntrada Therapeutics, Inc.10% ownerSell25,131$7.19$181K−0.8%
Sep 1TRDAEntrada Therapeutics, Inc.10% ownerSell29,088$7.06$205K+1.0%
Aug 31TRDAEntrada Therapeutics, Inc.10% ownerSell44,259$6.99$309K+2.0%
Aug 28TRDAEntrada Therapeutics, Inc.10% ownerSell3,733$7.01$26K+1.7%
Aug 27TRDAEntrada Therapeutics, Inc.10% ownerSell38,922$7.20$280K−1.0%
Aug 26TRDAEntrada Therapeutics, Inc.10% ownerSell14,569$7.06$103K+1.0%
Aug 25TRDAEntrada Therapeutics, Inc.10% ownerSell26,522$7.54$200K−5.4%
Aug 24TRDAEntrada Therapeutics, Inc.10% ownerSell21,623$7.34$159K−2.9%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.